GenSight Biologics S.A. (EPA:SIGHT)
France
· Delayed Price · Currency is EUR 0.2310
+0.0005 (0.22%)
Apr 2, 2025, 4:22 PM CET
GenSight Biologics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 2.46 | 2.13 | 10.61 | 44.29 | 37.94 | Upgrade
|
| Cash & Short-Term Investments | 2.46 | 2.13 | 10.61 | 44.29 | 37.94 | Upgrade
|
| Cash Growth | 15.46% | -79.89% | -76.04% | 16.72% | 97.11% | Upgrade
|
| Accounts Receivable | 0 | 0 | - | 0.75 | 0.05 | Upgrade
|
| Other Receivables | - | 2.4 | 3.49 | 3.54 | 3.21 | Upgrade
|
| Receivables | 0 | 2.4 | 3.49 | 4.3 | 3.26 | Upgrade
|
| Prepaid Expenses | - | 1.63 | 8.21 | 2.55 | 1.67 | Upgrade
|
| Other Current Assets | 2.88 | 0.37 | 0.63 | 2.23 | 0.89 | Upgrade
|
| Total Current Assets | 5.34 | 6.53 | 22.95 | 53.36 | 43.76 | Upgrade
|
| Property, Plant & Equipment | 0.93 | 2.03 | 2.27 | 2.55 | 3.15 | Upgrade
|
| Other Intangible Assets | 0.06 | 0.08 | 0.09 | 0.11 | 0.13 | Upgrade
|
| Other Long-Term Assets | 4.42 | 0.5 | 0.63 | 0.62 | 0.32 | Upgrade
|
| Total Assets | 10.76 | 9.13 | 25.94 | 56.65 | 47.36 | Upgrade
|
| Accounts Payable | 6.36 | 5.63 | 7.81 | 11.56 | 7.59 | Upgrade
|
| Accrued Expenses | - | 1.79 | 3.61 | 2.45 | 2.64 | Upgrade
|
| Current Portion of Long-Term Debt | 13.31 | 16.61 | 1.54 | 4.68 | 2.41 | Upgrade
|
| Current Portion of Leases | 0.59 | 0.78 | 0.89 | 0.74 | 0.56 | Upgrade
|
| Current Income Taxes Payable | - | 0.03 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Current Unearned Revenue | - | 0.07 | 0.03 | 0.2 | 0.04 | Upgrade
|
| Other Current Liabilities | 2.36 | 0.4 | 0.73 | 2.6 | 3.87 | Upgrade
|
| Total Current Liabilities | 22.62 | 25.29 | 14.64 | 22.24 | 17.12 | Upgrade
|
| Long-Term Debt | 4.7 | 5.11 | 14.46 | 10.58 | 14.12 | Upgrade
|
| Long-Term Leases | 0.51 | 1.05 | 0.97 | 1.51 | 2.05 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 0.19 | 0.42 | - | Upgrade
|
| Other Long-Term Liabilities | 8.68 | 7.13 | 10.93 | 5.86 | 2.29 | Upgrade
|
| Total Liabilities | 37.68 | 39.83 | 41.22 | 40.66 | 35.61 | Upgrade
|
| Common Stock | 3.12 | 1.63 | 1.16 | 1.16 | 1.02 | Upgrade
|
| Additional Paid-In Capital | 206.61 | 190.94 | 181.21 | 181.18 | 152.78 | Upgrade
|
| Retained Earnings | -14 | -26.22 | -27.63 | -28.62 | -34.02 | Upgrade
|
| Comprehensive Income & Other | -222.64 | -197.05 | -170.02 | -137.73 | -108.03 | Upgrade
|
| Shareholders' Equity | -26.92 | -30.7 | -15.28 | 15.99 | 11.75 | Upgrade
|
| Total Liabilities & Equity | 10.76 | 9.13 | 25.94 | 56.65 | 47.36 | Upgrade
|
| Total Debt | 19.11 | 23.54 | 17.86 | 17.51 | 19.13 | Upgrade
|
| Net Cash (Debt) | -16.65 | -21.4 | -7.25 | 26.78 | 18.81 | Upgrade
|
| Net Cash Growth | - | - | - | 42.36% | 123.47% | Upgrade
|
| Net Cash Per Share | -0.17 | -0.44 | -0.16 | 0.59 | 0.54 | Upgrade
|
| Filing Date Shares Outstanding | 108.85 | 64.97 | 46.18 | 46.24 | 45.93 | Upgrade
|
| Total Common Shares Outstanding | 108.85 | 64.97 | 46.18 | 46.24 | 45.93 | Upgrade
|
| Working Capital | -17.28 | -18.76 | 8.31 | 31.12 | 26.64 | Upgrade
|
| Book Value Per Share | -0.25 | -0.47 | -0.33 | 0.35 | 0.26 | Upgrade
|
| Tangible Book Value | -26.98 | -30.78 | -15.37 | 15.88 | 11.62 | Upgrade
|
| Tangible Book Value Per Share | -0.25 | -0.47 | -0.33 | 0.34 | 0.25 | Upgrade
|
| Machinery | - | 1.23 | 1.22 | 1.36 | 1.31 | Upgrade
|
| Leasehold Improvements | - | 1.35 | 1.37 | 0.98 | 0.96 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.